Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Decentralized Trials
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Decentralized Trials
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
NeoGenomics
MedTech
NeoGenomics moves forward with $390M option to buy out Inivata
The deal is expected to close in June, at which time Inivata’s business will become a separate liquid biopsy division under the NeoGenomics umbrella.
Andrea Park
May 6, 2021 12:27pm
NeoGenomics to acquire Genoptix in near $140M deal
Oct 26, 2018 10:35am
PPD, NeoGenomics to integrate lab testing for cancer trials
Jun 1, 2018 11:28am
